Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GREGORY B BROWN Insider Profile
4 Followers
GREGORY B BROWN, Director at Lisata Therapeutics, holds 49.41K shares in Lisata Therapeutics (Ticker: LSTA), holds 0.00 shares in Cambrex (Ticker: CBM), holds 75.08K shares in Aquestive Therapeutics (Ticker: AQST).
GREGORY B BROWN has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that GREGORY B BROWN holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by GREGORY B BROWN
GREGORY B BROWN's Trading History
Lisata Therapeutics
Jan 11, 2024
Director
Uninformative Buy
―
$130.80K
Cambrex
Dec 05, 2019
―
Informative Buy
233.05K
$0.00
Aquestive Therapeutics
―
Director
―
$305.60K
List of latest transactions for each holding click on a transaction to see GREGORY B BROWN's performance on stock
You May Also Like
GREGORY B BROWN insider profile FAQ
What is the percentage of profitable transactions made by GREGORY B BROWN?
The percentage of profitable transactions made by GREGORY B BROWN is ―.
What is the average return per transaction made by GREGORY B BROWN?
The average return per transaction made by GREGORY B BROWN is ―.
What stocks does GREGORY B BROWN hold?
GREGORY B BROWN holds: LSTA, CBM, AQST stocks.
What was GREGORY B BROWN’s latest transaction?
GREGORY B BROWN latest transaction was an Uninformative Buy of ―.
What was GREGORY B BROWN's most profitable transaction?
GREGORY B BROWN’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is GREGORY B BROWN's role in Lisata Therapeutics?
GREGORY B BROWN's role in Lisata Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.